𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder

✍ Scribed by Marc Ansseau; Jean-Piérre Olié; Remy Frenckell; Gonzague Jourdain; Brigitte Stehle; Philippe Guillet


Publisher
Springer
Year
1991
Tongue
English
Weight
549 KB
Volume
104
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy and tolerability of duloxetine
✍ Jonathan Davidson; Christer Allgulander; Mark H. Pollack; James Hartford; Janell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of dulo

Escitalopram in the treatment of general
✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Efficacy of ondansetron in the treatment
✍ A. M. Freeman III; J. R. Westphal; G. T. Norris; B. A. Roggero; P. B. Webb; K. L 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Ondansetron is a highly selective antagonist at the 5-HT 3 subtype of serotonin (5-HT) receptors . The 5-HT 3 receptors are the only receptors whose effects are mediated through the ion channels rather than the G-protein series . Ondansetron has no appreciable affinity for other 5-HT receptor subtyp